4basebio PLC (4BB.L) LSE

890.00

-10(-1.11%)

Updated at August 18 03:52PM

Currency In GBp

Valuation

Market Cap158.71M
Enterprise Value139.32M
P/E Ratio-9.32
PEG Ratio0.43
Price/Sales Ratio147.71
Price/Book Ratio4.36
Enterprise/Revenue126.93
Enterprise/EBITDA-8.82

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-13.22
Operating Margin-17.85

Management Effectiveness

Return On Assets-0.28
Return On Equity-1.17

Income Statement

Revenue933,000
Revenue/Share0.07
Gross Profit630,000
EBITDA-10.97M
Net Income-12.33M
Diluted EPS-0.94

Balance Sheet

Total Cash34.6M
Total Cash/Share2.68
Total Debt15.22M
Total Debt/Equity0.58
Current Ratio11.3
Book Value Per Share2.04

Price History

52-Week Change-35.97
52-Week High1,540
52-Week Low870
Moving Average 50 Days982.5
Moving Average 200 Days1,127.13

Statistics

Average Volume1,207
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A